Hua Ying
15Patents
3h-index
39Co-inventors
56Inventor score
Filing activity: Sep 7, 2007 → Mar 15, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7915388B2 | Interleukin-13 binding proteins | Emerging Cross-Sectional Technologies | 79 | Active |
| US9029508B2 | Dual variable domain immunoglobulins and uses thereof | Emerging Cross-Sectional Technologies | 53 | Active |
| US9592293B2 | Interleukin-13 binding proteins | Emerging Cross-Sectional Technologies | 16 | Active |
| US8604177B2 | Interleukin-13 binding proteins | Emerging Cross-Sectional Technologies | 3 | Active |
| US10086076B2 | Interleukin-13 binding proteins | Emerging Cross-Sectional Technologies | 2 | Active |
| US11072658B2 | Anti-PD-1/LAG3 bispecific antibodies | Chemistry; Metallurgy | 2 | Active |
| US12202891B2 | Antibody capable of binding to thymic stromal lymphopoietin and use thereof | Chemistry; Metallurgy | 1 | Active |
| US12377163B2 | Anti-B7H3 antibody-exatecan analog conjugate and medicinal use thereof | Chemistry; Metallurgy | 0 | Active |
| US12258394B2 | IL-5 antibody, antigen binding fragment thereof, and medical application therefor | Physics | 0 | Active |
| US11344621B2 | Interleukin-13 binding proteins | Emerging Cross-Sectional Technologies | 0 | Active |
| US12122834B2 | Anti-PD-1 antibodies | Chemistry; Metallurgy | 0 | Active |
| US11365247B2 | IL-5 antibody, antigen binding fragment thereof, and medical application therefor | Physics | 0 | Active |
| US12325741B2 | Anti-Aβ antibodies and antigen-binding fragments thereof | Chemistry; Metallurgy | 0 | Active |
| US12258405B2 | CD3 antibody and pharmaceutical use thereof | Chemistry; Metallurgy | 0 | Active |
| US12404323B2 | Antibody capable of binding to thymic stromal lymphopoietin and use thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.